HomeStocksSMSPHARMA

S

SMS Pharmaceuticals

SMSPHARMA Share Price

Healthcare
mtf MTF 2.00x

233.77

3.80 (1.65%)profit

as on 13 Aug 2025 at 15:29

1D
Bulb

Today SMS Pharmaceuticals opened at 229.97 while its previous close was at 229.97. In todays trading session SMSPHARMA reached a high of 239.00 and low of 229.00. The average traded price for today is 233.45. The 50 DMA stands at 17.53 and 200 DMA is at 11.22. Looking at intraday trend, the stock is in Uptrend.

chartsarrowTradingViewarrow
TradingView Logo

Get 10+ Layouts, 100+ Indicators, Custom Timeframes & All Drawing Tools for FREE.

SMSPHARMA Stock Performance

Markets Today

High

239.00

Low

229.00

Open at

229.97

Prev Close

229.97

Volumes

1,03,209

Avg Price

233.45

Lower Circuit

187.01

Upper Circuit

280.52

Last Traded Details

Quantity

30

Time

15:29:59

Price Movement

229.00
233.77
239.00
Loss 2.08%down side
up side2.19% profit

Historical Performance

3 M High

275.00

3 M Low

207.70

1 Yr High

398.00

1 Yr Low

176.05

3 Yr High

398.00

3 Yr Low

54.55

5 Yr High

398.00

5 Yr Low

54.55

1-Year Performance

176.05
233.77
398.00
loss2.08%down side
up side2.19% profit

SMSPHARMA News

View All News arrow

DIC India Approves Q1 FY2026 Results and Appoints New Director

sentiment_img

DIC India Limited's Board of Directors approved unaudited financial results for the quarter and half year ended June 30, 2025, during a meeting held on August 13, 2025. The board appointed Mr. Navapol Chuensiri as an additional Non-Executive Non-Independent Director effective August 13, 2025. Mr. Chuensiri serves as Deputy Regional Managing Director of DIC Asia Pacific Pte Ltd and brings 30 years of leadership experience from global companies including SIG Combibloc, Tetra Pak, Amcor, Goodyear Tyre & Rubber, and O-I Glass. The company will seek shareholder approval for his appointment through postal ballot with a cut-off date of September 5, 2025. The board also authorized the Company Secretary and Chief Financial Officer to determine materiality of events for stock exchange disclosures and appointed Karan Arora & Associates as scrutinizer for the postal ballot.

17 seconds ago

Indef Manufacturing Appoints Vandan Shah as Director, Re-appoints Shekhar Bajaj at Annual General Meeting

sentiment_img

Indef Manufacturing Limited shareholders approved two key board appointments at their 3rd Annual General Meeting held on August 12, 2025. Mr. Vandan Sitaram Shah was appointed as a Non-Executive, Non-Independent Director effective May 27, 2025. Shah brings 39 years of manufacturing experience as Owner and Executive Chairman of Sipra Engineers Pvt. Ltd., an aluminium die-casting company serving automotive and industrial sectors globally. He previously served as Independent Director on boards of Hind Rectifiers Ltd. and Hercules Hoists Ltd. Separately, Shri Shekhar Bajaj was re-appointed as Non-Executive, Non-Independent Director upon retirement by rotation. Bajaj serves as Chairman of Bajaj Electricals Limited, Hercules Hoists Limited and Bajaj Holding & Investment Limited, and has been a director of Indef Manufacturing since September 12, 2022. Both directors are liable to retire by rotation and are not related to any other directors on the board.

3 minutes ago

D&H India Limited Announces Board Changes and New Auditor Appointments

sentiment_img

D&H India Limited approved multiple leadership and auditor changes during its 40th Annual General Meeting held on August 13, 2025. The company confirmed the appointment of Mr. Niranjan Shastri as Non-Executive Independent Director for a five-year term starting May 14, 2025. Mr. Shastri holds CMA/CS qualifications and brings nearly 20 years of cost accounting experience. Mrs. Atithi Vora was appointed as Whole-time Director for three years from April 1, 2025. She is a Chartered Accountant with 10 years of experience and is the spouse of Whole-time Director Mr. Saurabh Vora and daughter-in-law of Chairman and Managing Director Mr. Harsh Vora. The company also appointed M/s D.K. Jain & Co. as Secretarial Auditors for five years and M/s ABN & Co. as Statutory Auditors for five years until the 45th AGM in 2030. The term of previous statutory auditor M/s Devpura Navlakha & Co. concluded after completing their five-year tenure.

5 minutes ago

SMSPHARMA Share Price History

View Price History arrow

Close Price

Volume

SMSPHARMA share price in last 10 trading sessions

DayOpenCloseChange%Day HighDay LowVolume
12 Aug 202522.9622.96
0.00% profit
22.9622.961,720
11 Aug 202523.4223.42
0.00% profit
23.4223.42758
08 Aug 202523.8923.89
0.00% profit
23.8923.89810
07 Aug 202524.3724.37
0.00% profit
24.3724.372,989
06 Aug 202524.8624.86
0.00% profit
24.8624.863,532
05 Aug 202525.3625.36
0.00% profit
25.3625.3616,227
04 Aug 202526.2025.87
-1.26% Loss
26.2025.8772,303
01 Aug 202525.7125.71
0.00% profit
25.7125.7121,623
31 Jul 202525.2125.21
0.00% profit
25.2125.213,693
30 Jul 202524.7524.72
-0.12% Loss
24.7524.7249,604

SMSPHARMA Fundamentals

View Fundamentals arrow

Company Valuation

Market Cap (₹ Cr.)

2,072

PE Ratio

27.90

PB Ratio

3.19

Dividend Yield

0.17%

ROE

9.17%

ROCE

12.75%

Book Value (₹)

72.15

Face Value (₹)

1.00


Share Holding Pattern

Held ByJun 2024Sep 2024Dec 2024Mar 2025Jun 2025
Promoters
64.67%64.67%64.67%66.26%66.26%
Domestic Institutional Investors (DII)
2.13%2.55%2.55%2.43%3.03%
Foreign Institutional Investors (FII)
0.17%0.52%0.31%0.08%0.03%
Public Investors
27.81%27.04%27.38%26.35%25.89%
Government
0.00%0.00%0.00%0.00%0.00%

Promoters

Domestic Institutional Investors (DII)

Foreign Institutional Investors (FII)

Public Investors

Government


SMSPHARMA Investment Returns

1 Week

1 Month

3 Months

6 Months

9 Months

SIP Logo

Create Wealth in Longterm with Weekly and Monthly SIP in Stocks.


SMSPHARMA Technicals

View Technicals arrow

Moving Averages

PeriodSimpleSignal
5-SMA23.43Bearish
10-SMA24.42Bearish
20-SMA24.24Bearish
50-SMA17.53Bullish
100-SMA14.57Bullish
200-SMA11.22Bullish

Technical Indicators

IndicatorValueAction
RSI(14)53.55Neutral
ATR(14)0.55Less Volatile
STOCH(9,6)5.96Oversold
STOCH RSI(14)-0.00Oversold
MACD(12,26)-0.72Bearish
ADX(14)54.37Very Strong Trend

Summary of Technical Indicators for SMSPHARMA


Margin on SMSPHARMA

Order TypeMargin to PayLeverageQuantityTrade ValueMargin AmountActions
Intraday100.00%1.00 X
233.77233.77
Delivery100.00%1.00 X
233.77233.77

*Calculated on NSE. Applicable on all exchanges. Margins are subject to change from time to time or may be withdrawn under volatile market conditions.Intraday Orders are square-off automatically at 03:19 pm on NSE / BSE or on hitting 80% of margin utilisation (whichever earlier).


SMSPHARMA Financials Summary
View By:
Revenue
EBITDA
Net Profit
EPS
Revenue

In Crores

Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025
166198176250197

SMSPHARMA Financials

View By:

Income Statement

In Crores

Quarterly StatementJun 2024Sep 2024Dec 2024Mar 2025Jun 2025
Revenue166198176250197
Expenses131165140207157
Operating Profit3432334139
Operating Profit Margin %20%16%19%16%20%
Other Income11211
EBITDA3533354240
Interest55456
Depreciation899910
Profit Before Tax2220222924
Tax %25%28%19%29%16%
Net Profit1714182021
EPS22222

Balance Sheet

In Crores

Yearly Balance SheetMar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Share Capital99999
Reserve & Surplus402462452499631
Minority Interest00000
Non Current Liabilities206193164166189
Current Liabilities195197255332324
Total Liabilities8128608801,0341,153
Fixed Assets457438412437568
Capital Work in Progress711333035
Investments27221111285
Other Assets3213894245560
Total Assets8128608801,0341,153

Cash Flow

In Crores

Yearly Cash FlowMar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Operating Activities4090452350
Investing Activities-43-152-27-30-52
Financing Activities-292-12-3231
Net Cash Flow-5316-3929

Corporate Actions

DateCorporate ActionInformation
22nd Sept 2025, Monday
DIVIDENDDividend
Final Dividend of ₹0.4 Per Share
9th Aug 2025, Saturday
QUARTERLY RESULT ANNOUNCEMENTStock Result
Q1 FY 25-26 Results
info
30th May 2025, Friday
QUARTERLY RESULT ANNOUNCEMENTStock Result
Q4 FY 25-26 Results
info
12th Feb 2025, Wednesday
QUARTERLY RESULT ANNOUNCEMENTStock Result
Q3 FY 24-25 Results
info
8th Nov 2024, Friday
QUARTERLY RESULT ANNOUNCEMENTStock Result
Q2 FY 24-25 Results
info

The above dates are ex-dates.

View All Stock Events arrow

SMSPHARMA Revenue Growth

All values are in Crores

Revenue

Profit

Loss

Financial YearRevenueRevenue GrowthNet ProfitProfit Growth
FY 2023-24783
35.86% profit
74
1110.03% profit
FY 2022-23714
0.42% profit
49
-94% Loss
FY 2021-22527
-7.69% Loss
4
11.6% profit






What’s New In The Market
icon
D

DIC India Approves Q1 FY2026 Results and Appoints New Director

sentiment_img

DIC India Limited's Board of Directors approved unaudited financial results for the quarter and half year ended June 30, 2025, during a meeting held on August 13, 2025. The board appointed Mr. Navapol Chuensiri as an additional Non-Executive Non-Independent Director effective August 13, 2025. Mr. Chuensiri serves as Deputy Regional Managing Director of DIC Asia Pacific Pte Ltd and brings 30 years of leadership experience from global companies including SIG Combibloc, Tetra Pak, Amcor, Goodyear Tyre & Rubber, and O-I Glass. The company will seek shareholder approval for his appointment through postal ballot with a cut-off date of September 5, 2025. The board also authorized the Company Secretary and Chief Financial Officer to determine materiality of events for stock exchange disclosures and appointed Karan Arora & Associates as scrutinizer for the postal ballot.

DICIND

593.45

8.00
(1.37%) profit
19 seconds ago

icon
B

Indef Manufacturing Appoints Vandan Shah as Director, Re-appoints Shekhar Bajaj at Annual General Meeting

sentiment_img

Indef Manufacturing Limited shareholders approved two key board appointments at their 3rd Annual General Meeting held on August 12, 2025. Mr. Vandan Sitaram Shah was appointed as a Non-Executive, Non-Independent Director effective May 27, 2025. Shah brings 39 years of manufacturing experience as Owner and Executive Chairman of Sipra Engineers Pvt. Ltd., an aluminium die-casting company serving automotive and industrial sectors globally. He previously served as Independent Director on boards of Hind Rectifiers Ltd. and Hercules Hoists Ltd. Separately, Shri Shekhar Bajaj was re-appointed as Non-Executive, Non-Independent Director upon retirement by rotation. Bajaj serves as Chairman of Bajaj Electricals Limited, Hercules Hoists Limited and Bajaj Holding & Investment Limited, and has been a director of Indef Manufacturing since September 12, 2022. Both directors are liable to retire by rotation and are not related to any other directors on the board.

BAJAJINDEF

371.40

-19.10
(-4.89%) profit
3 minutes ago

icon
D

D&H India Limited Announces Board Changes and New Auditor Appointments

sentiment_img

D&H India Limited approved multiple leadership and auditor changes during its 40th Annual General Meeting held on August 13, 2025. The company confirmed the appointment of Mr. Niranjan Shastri as Non-Executive Independent Director for a five-year term starting May 14, 2025. Mr. Shastri holds CMA/CS qualifications and brings nearly 20 years of cost accounting experience. Mrs. Atithi Vora was appointed as Whole-time Director for three years from April 1, 2025. She is a Chartered Accountant with 10 years of experience and is the spouse of Whole-time Director Mr. Saurabh Vora and daughter-in-law of Chairman and Managing Director Mr. Harsh Vora. The company also appointed M/s D.K. Jain & Co. as Secretarial Auditors for five years and M/s ABN & Co. as Statutory Auditors for five years until the 45th AGM in 2030. The term of previous statutory auditor M/s Devpura Navlakha & Co. concluded after completing their five-year tenure.

5 minutes ago

FAQs

SMS Pharmaceuticals share price as of today is ₹ 233.77 as on 13 Aug 2025 at 15:29.
The 52W high of SMS Pharmaceuticals is ₹ 398.00 and 52W low is ₹ 176.05 as of 13 Aug 2025 at 15:29.
The past returns of SMS Pharmaceuticals share are -
  • Past 1 year: -16.72%
  • Past 3 years: 186.31%
  • Past 5 years: 140.38%
The PE and PB ratio of SMS Pharmaceuticals stands at 27.90 and 3.19 respectively as on 13 Aug 2025 at 15:29.
The EPS of SMS Pharmaceuticals is 2.31 for the quarter ended Jun 2025 and 8.16 for the financial year 2024-25.
The shareholding pattern of SMS Pharmaceuticals is as follows:
  • DIIs - 3.03%
  • FII - 0.03%
  • Promoters - 66.26%
  • Public Investors 25.89%
  • Goverenment - 0.00%
Yes, you can buy shares of SMS Pharmaceuticals online by opening Demat account with Dhan.
If you are a Dhan user already, you can buy SMS Pharmaceuticals stocks from Dhan Trading App or Web Trading Platform. If you are new to Dhan follow the below steps:
  1. Download the Dhan App to Open a Demat Account
  2. Navigate to the “Money Tab”
  3. Add money to your account
  4. Search for SMS Pharmaceuticals share
  5. Tap on “Buy”
With Dhan you can start a daily, weekly or monthly SIP in SMS Pharmaceuticals.
You can easily buy the shares of SMS Pharmaceuticals even after the markets are closed using the After Market Order feature on Dhan Trading App.
Candle bars with Screen
Invest in SMSPHARMA
Candle bars with Screen

Pay Zero Brokerage on Delivery

Candle bars with Screen

Open FREE Demat Account

Indian Flag

+91

Or Scan the QR Code to download the Dhan App

QR code Logo


Invest & Trade with a Trading
Platform That's icon

Open your Dhan Account in minutes!


border

Explore  |  Sitemap

*All securities mentioned on this website are exemplary and not recommendatory.

*Current prices on the website are delayed by 15 mins, login to check live prices.

We are bullish on India, we are bullish on India's prospects to be one of the largest economies in the world. We believe that the stock market provides a unique opportunity for all of India's traders and investors to participate in the growth story of the country.

Yet, most investing & trading platforms in India have remained more or less the same over the past decade. Times have changed and retail traders and investors have become smarter about managing their trades and money. Modern traders & investors require an online trading platform that helps them keep up with the technological advancements of our time.

That's why we're building Dhan - to help you trade, to help you invest, and to help you participate in India's growth stock via the stock market with awesome features and an incredible experience.

©2021-2025 Raise Securities Private Limited (formerly Moneylicious Securities Private Limited). All rights reserved. CIN: U74999MH2012PTC433549 Raise Securities is part of Raise Financial Services.

SEBI Stock Broker Registration No: INZ000006031 | Depository Participant (CDSL) ID: IN-DP-289-2016
Exchange Membership No. : NSE: 90133 | BSE: 6593 | MCX: 56320
Registered Office: Unit No. 2201, 22nd Floor, Gold Medal Avenue, S.V. Road, Beside Patel Petrol Pump, Piramal Nagar, Goregaon West, Mumbai – 400104
Corporate Office: 302, The Western Edge I, Off Western Express Highway, Borivali East, Mumbai - 400066, Maharashtra, India. Customer Care: 9987761000.


For any query / feedback / clarifications, email at help@dhan.co.

In case of grievances for any of the services rendered by Raise Securities Private Limited, please write to grievance@dhan.co (for NSE, BSE and MCX) or grievancedp@dhan.co (for Depository Participant). Please ensure that you carefully read the Risk Disclosure Document as prescribed by SEBI, our Terms of Use and Privacy Policy. Compliance Officer: Mr. Manish Garg and Mobile: 8655740961 Email: complianceofficer@dhan.co To lodge your complaints using SEBI SCORES, click here.


Disclaimer: All communications with the client via chat, phone, or email are for support purposes only. Any commitments or statements made by the agent (human or virtual) shall not be binding on the company.


DHAN is a brand owned by Raise Securities Private Limited. All DHAN clients are registered under Raise Securities Private Limited. Clients are advised to refer to our company as Raise Securities Private Limited when communicating with regulatory authorities.


Procedure to file a complaint on SEBI SCORES: Register on SCORES portal. Mandatory details for filing complaints on SCORES: Name, PAN, Address, Mobile Number, E-mail ID. Benefits: Effective Communication, Speedy redressal of the grievances


Disclaimer: Investment in the securities market are subject to market risks, read all the related documents carefully before investing. Brokerage will not exceed the SEBI prescribed limit


Attention investors:

  1. Stock brokers can accept securities as margins from clients only by way of pledge in the depository system w.e.f September 01, 2020.
  2. Update your e-mail and phone number with your stock broker / depository participant and receive OTP directly from depository on your e-mail and/or mobile number to create pledge.
  3. Check your securities / MF / bonds in the consolidated account statement issued by NSDL/CDSL every month.

Note: As a policy we do not give stock tips or recommendations and have not authorized anyone to give this on behalf of us. If you know anyone claiming to be a part of Dhan / / Raise or our associate companies or partners and offering such services, please report us on help@dhan.co. Important Information for Investors: To prevent unauthorized transactions in your trading / demat account, do not share your account details, credentials or any personal details with anyone. Keep your mobile number updated with your Stock Broker, Depository Participant and ensure that the same is registered with Stock Exchanges, Depository and KRAs. You will receive alerts and information on your registered mobile number / email for debit and other important transactions in your demat account directly from CDSL / Exchange on the same day. KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (Stock Broker, DP, Mutual Fund, etc.), you need not undergo the same process again when you approach another intermediary. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account. This is issued in the interest of investors.


Raise Securities Private Limited also known as Dhan is only an order collection platform that collects orders on behalf of clients and places them on BSE StarMF for execution. Client expressly agrees that Dhan is not liable or responsible and does not represent or warrant any damages regarding non- execution of orders or any incorrect execution of orders with regard to the funds chosen by the client or due to, but not being limited to, any link/system failure, delay in transfer of the funds on account of any unforeseen circumstances/issues in the banking system/payment aggregators or any other problems that may result in a delay in crediting the funds into the BSE Star MF's bank account.


Mutual fund investments are subject to market risks, read all scheme related documents carefully before investing. Dhan is not a distributor or agent of any mutual fund. Mutual Funds are not exchange-traded products. Any related disputes will not have access to the Exchange-investor redressal forum or arbitration mechanism. For other disclaimers please refer https://dhan.co/advertisement-disclaimer/


Download client registration documents (Rights & Obligations, Risk Disclosure Document, Do's & Don'ts) in vernacular language: BSE | NSE | MCX


Kindly, read the Advisory Guidelines of BSE | NSE | MCX for investors as prescribed by the exchange with reference to their circular dated 27th August, 2021 regarding investor awareness and safeguarding client's assets


Important Links: SEBI | BSE | NSE | MCX | CDSL | SCORES | ODR Portal | Investor Charter for Stock Brokers | Investor Charter for DP | UCC Advisory | e-Voting for Shareholders | NCL Client Collateral details |
MCXCCL Client Collateral details

Important Information: Terms of Usage | Disclaimers | Privacy Policy | Grievances | Risk Management Policy | Risk Disclosure | Advertisement Disclaimer | Referral Terms & Conditions | Saarthi 2.0 Mobile App for Investors